Proteome Sciences PLC - drug development services provider - Achieves ‘cumulative sales milestone’ with life sciences company Thermo Fisher Scientific Inc. Says a payment of £870,000 has been received by the company and will be recognised in the 2022 financial year. Proteome Sciences has an exclusive licence and distributor agreement with Thermo Scientific.

Current stock price: 3.50 pence

12-month change: down 33%

Copyright 2023 Alliance News Ltd. All Rights Reserved.